Program
DAY 1
Wednesday, 27 November 2024
8h30
Registration & welcome coffee
9h10
Welcome Address
9h15
Opening lectures
- Plenary
Chairman
9h15
Discovery and Characterization of Zosurabalpin
Claudia Zampaloni
Senior Principal Scientist
Roche - Switzerland
9h45
Systems-level analyses of human immunity
Petter Brodin
Professor
Imperial college London - United Kingdom
Karolinska Institute - Sweden
10h15
Coffe Break - Exhibition Hall - B2B Meetings
10h45
Track 1: Alternatives to current antibiotics
- Plenary
Chairman
10h45
Application of phage therapy in infectious diseases
Mariagrazia Di Luca
Assistant Professor in Microbiology
University of Pisa - Italy
11h05
Strategies and solutions for Antimicrobial Resistance (AMR): Endolysins as Novel Adjuncts to Antibiotic Therapies
Martin Everett
CSO
Aurobac - France
11h25
A Human Lung Tissue Model to Study - Pseudomonas aeruginosa Infection and Treatment
Urs Jenal
Swiss Microbiologist and Professor
Biozentrum - University of Basel - Switzerland
11h45
Phage lysins for transformative innovation of the antibiotics market
Yves Briers
CSO
Obulytix - Belgium
12h05
Q&A session
12h20
Lunch - Exhibition Hall - B2B Meetings 2 slots
Poster Presentation - Exhibition Hall - B2B Meetings 3 slots
14h00
Track 2 : Immunotherapies & new biotherapeutics
- Plenary
Chairman
14h00
Broad spectrum biotherapies for emergency prepardness
Mariagrazia Di Luca
Assistant Professor in Microbiology
Fab'entech - France
14h20
The potential of broadly neutralizing antibodies to prevent and treat HIV-1 infection
Florian Klein
Professor and Director
University Hospital of Cologne - Germany
14h40
Breaking new ground - targeting the gut microbiota in systemic autoimmunity
Carina Brune
Pharmacist
University of Münster - Germany
15h00
Regulation of immune genes by long noncoding RNAs
Stephanie Fanucchi
Postdoctoral Researcher
Lemba Therapeutics - Netherlands
15h20
Q&A session
15h35
Coffe Break - Exhibition Hall - B2B Meetings 3 slots
16h15
Breakthrough innovation Session 1
- Plenary
Chairman
14h00
Keynote lecture
Mariagrazia Di Luca
Assistant Professor in Microbiology
Fab'entech - France
17h45
End of DAY 1
DAY 2
Thursday, 28 November 2024
9h00
Welcome coffee
9h30
Opening lectures
- Plenary
Chairman
9h30
Progress in TB vaccine discovery and development
Willem Hanekom
Director
Africa Health Research Institute (AHRI) - South Africa
10h00
Shifts in pandemic medical countermeasures – Global Preparedness Monitoring Board
Sylvie Briand
Director
Pandemic and Epidemic Diseases Department
at the World Health Organization (WHO) - France
10h30
Coffe Break - Exhibition Hall - B2B Meetings
11h00
Track 3 : Latest developments in Vaccines
- sponsored by Sanofi
Chairman
11h00
General view of latest vaccine developments by Sanofi
Behazine Combadiere
Global head of early stage Immunology at sanofi Vaccines
Sanofi - France
11h20
Harnessing Innate Immune Memory Against Infection and Beyond
Jessica Quintin
Head of the Immunology of Fungal Infections Unit
Institut Pasteur - France
11h40
Title to be confirmed
Urs Jenal
Swiss Microbiologist and Professor
Valneva - France
12h00
Q&A session
12h15
Lunch - Exhibition Hall - B2B Meetings 2 slots
Poster Presentation - Exhibition Hall - B2B Meetings 3 slots
14h00
Track 3 : Latest developments in Vaccines
- sponsored by Sanofi
Chairman
14h00
Latest results for Metavac®-RSV, a mucosal bivalent live attenuated vaccine
Julia Dubois
Researcher scientist
Laboratoire VirPath, CIRI - France
14h20
Title to be confirmed
Julia Dubois
Researcher scientist
Boehringer Ingenheim – France
15h20
Q&A session
15h35
Coffe Break - Exhibition Hall - B2B Meetings
16h10
Track 4 : Diagnostic Prognostic and theragnostic Biomarkers
- Plenary
Chairman
16h10
How a multiplex lateral flow immunoassay is helping clinicians worldwide combat antimicrobial resistance.
Milovan Stankov-Pugès
CEO
NG Biotech - France
17h30
Q&A session
17h45
Annoucemment of next year edition
18h00
